Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
19.12
+0.05 (0.26%)
At close: Feb 21, 2025, 4:00 PM
19.46
+0.34 (1.78%)
After-hours: Feb 21, 2025, 4:48 PM EST
Cellebrite DI Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Cellebrite DI stock have an average target of 22, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 15.06% from the current stock price of 19.12.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cellebrite DI stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $17 → $26 | Strong Buy | Maintains | $17 → $26 | +35.98% | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +46.44% | Feb 14, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $24 → $28 | Buy | Maintains | $24 → $28 | +46.44% | Feb 11, 2025 |
| Needham | Needham | Strong Buy Maintains $21 → $28 | Strong Buy | Maintains | $21 → $28 | +46.44% | Jan 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +25.52% | Dec 16, 2024 |
Financial Forecast
Revenue This Year
493.85M
from 401.20M
Increased by 23.09%
Revenue Next Year
580.81M
from 493.85M
Increased by 17.61%
EPS This Year
0.41
from -1.35
EPS Next Year
0.51
from 0.41
Increased by 24.00%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 512.4M | 615.3M | 731.9M | |
| Avg | 493.9M | 580.8M | 682.2M | |
| Low | 470.4M | 545.9M | 627.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 27.7% | 24.6% | 26.0% | |
| Avg | 23.1% | 17.6% | 17.5% | |
| Low | 17.2% | 10.5% | 8.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.47 | 0.61 | 0.56 | |
| Avg | 0.41 | 0.51 | 0.54 | |
| Low | 0.27 | 0.35 | 0.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 49.3% | 10.0% | |
| Avg | - | 24.0% | 6.9% | |
| Low | - | -13.5% | 2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.